Medical - Diagnostics & Research
Compare Stocks
2 / 10Stock Comparison
RDNT vs SMID
Revenue, margins, valuation, and 5-year total return — side by side.
Construction Materials
RDNT vs SMID — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Diagnostics & Research | Construction Materials |
| Market Cap | $4.54B | $184M |
| Revenue (TTM) | $2.04B | $89M |
| Net Income (TTM) | $47M | $12M |
| Gross Margin | 11.2% | 28.0% |
| Operating Margin | 3.0% | 17.6% |
| Forward P/E | 91.8x | 23.9x |
| Total Debt | $1.86B | $5M |
| Cash & Equiv. | $767M | $8M |
RDNT vs SMID — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| RadNet, Inc. (RDNT) | 100 | 337.4 | +237.4% |
| Smith-Midland Corpo… (SMID) | 100 | 729.6 | +629.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: RDNT vs SMID
Each card shows where this stock fits in a portfolio — not just who wins on paper.
RDNT is the clearest fit if your priority is income & stability and sleep-well-at-night.
- Dividend streak 0 yrs, beta 1.43
- Lower volatility, beta 1.43, current ratio 1.76x
- Beta 1.43, current ratio 1.76x
SMID carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 31.8%, EPS growth 8.7%, 3Y rev CAGR 15.7%
- 14.2% 10Y total return vs RDNT's 9.7%
- 31.8% revenue growth vs RDNT's 11.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 31.8% revenue growth vs RDNT's 11.5% | |
| Value | Lower P/E (23.9x vs 91.8x) | |
| Quality / Margins | 13.2% margin vs RDNT's 2.3% | |
| Stability / Safety | Beta 1.43 vs SMID's 1.58 | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +12.3% vs RDNT's +10.0% | |
| Efficiency (ROA) | 13.8% ROA vs RDNT's 1.3%, ROIC 21.2% vs 2.0% |
RDNT vs SMID — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
RDNT vs SMID — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
SMID leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
RDNT is the larger business by revenue, generating $2.0B annually — 23.0x SMID's $89M. SMID is the more profitable business, keeping 13.2% of every revenue dollar as net income compared to RDNT's 2.3%. On growth, RDNT holds the edge at +14.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $2.0B | $89M |
| EBITDAEarnings before interest/tax | $214M | $18M |
| Net IncomeAfter-tax profit | $47M | $12M |
| Free Cash FlowCash after capex | -$178M | $5M |
| Gross MarginGross profit ÷ Revenue | +11.2% | +28.0% |
| Operating MarginEBIT ÷ Revenue | +3.0% | +17.6% |
| Net MarginNet income ÷ Revenue | +2.3% | +13.2% |
| FCF MarginFCF ÷ Revenue | -8.7% | +5.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +14.8% | -9.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -114.1% | -8.5% |
Valuation Metrics
RDNT leads this category, winning 3 of 4 comparable metrics.
Valuation Metrics
On an enterprise value basis, SMID's 14.4x EV/EBITDA is more attractive than RDNT's 26.3x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $4.5B | $184M |
| Enterprise ValueMkt cap + debt − cash | $5.6B | $181M |
| Trailing P/EPrice ÷ TTM EPS | -234.56x | 23.86x |
| Forward P/EPrice ÷ next-FY EPS est. | 91.75x | — |
| PEG RatioP/E ÷ EPS growth rate | — | 0.78x |
| EV / EBITDAEnterprise value multiple | 26.30x | 14.42x |
| Price / SalesMarket cap ÷ Revenue | 2.22x | 2.34x |
| Price / BookPrice ÷ Book value/share | 3.25x | 4.40x |
| Price / FCFMarket cap ÷ FCF | 53.04x | — |
Profitability & Efficiency
SMID leads this category, winning 9 of 9 comparable metrics.
Profitability & Efficiency
SMID delivers a 22.6% return on equity — every $100 of shareholder capital generates $23 in annual profit, vs $4 for RDNT. SMID carries lower financial leverage with a 0.12x debt-to-equity ratio, signaling a more conservative balance sheet compared to RDNT's 1.37x. On the Piotroski fundamental quality scale (0–9), SMID scores 7/9 vs RDNT's 5/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +3.8% | +22.6% |
| ROA (TTM)Return on assets | +1.3% | +13.8% |
| ROICReturn on invested capital | +2.0% | +21.2% |
| ROCEReturn on capital employed | +2.1% | +20.1% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 |
| Debt / EquityFinancial leverage | 1.37x | 0.12x |
| Net DebtTotal debt minus cash | $1.1B | -$2M |
| Cash & Equiv.Liquid assets | $767M | $8M |
| Total DebtShort + long-term debt | $1.9B | $5M |
| Interest CoverageEBIT ÷ Interest expense | 1.46x | 72.70x |
Total Returns (Dividends Reinvested)
SMID leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in SMID five years ago would be worth $27,074 today (with dividends reinvested), compared to $25,585 for RDNT. Over the past 12 months, SMID leads with a +12.3% total return vs RDNT's +10.0%. The 3-year compound annual growth rate (CAGR) favors SMID at 28.5% vs RDNT's 26.8% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -17.4% | -7.7% |
| 1-Year ReturnPast 12 months | +10.0% | +12.3% |
| 3-Year ReturnCumulative with dividends | +104.0% | +112.1% |
| 5-Year ReturnCumulative with dividends | +155.8% | +170.7% |
| 10-Year ReturnCumulative with dividends | +972.0% | +1418.5% |
| CAGR (3Y)Annualised 3-year return | +26.8% | +28.5% |
Risk & Volatility
Evenly matched — RDNT and SMID each lead in 1 of 2 comparable metrics.
Risk & Volatility
RDNT is the less volatile stock with a 1.43 beta — it tends to amplify market swings less than SMID's 1.58 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SMID currently trades 79.2% from its 52-week high vs RDNT's 68.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.43x | 1.58x |
| 52-Week HighHighest price in past year | $85.84 | $43.66 |
| 52-Week LowLowest price in past year | $50.76 | $25.56 |
| % of 52W HighCurrent price vs 52-week peak | +68.3% | +79.2% |
| RSI (14)Momentum oscillator 0–100 | 53.0 | 58.4 |
| Avg Volume (50D)Average daily shares traded | 820K | 9K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | — |
| Price TargetConsensus 12-month target | $92.00 | — |
| # AnalystsCovering analysts | 11 | — |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | 0 | 0 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
SMID leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). RDNT leads in 1 (Valuation Metrics). 1 tied.
RDNT vs SMID: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is RDNT or SMID a better buy right now?
For growth investors, Smith-Midland Corporation (SMID) is the stronger pick with 31.
8% revenue growth year-over-year, versus 11. 5% for RadNet, Inc. (RDNT). Smith-Midland Corporation (SMID) offers the better valuation at 23. 9x trailing P/E, making it the more compelling value choice. Analysts rate RadNet, Inc. (RDNT) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — RDNT or SMID?
Over the past 5 years, Smith-Midland Corporation (SMID) delivered a total return of +170.
7%, compared to +155. 8% for RadNet, Inc. (RDNT). Over 10 years, the gap is even starker: SMID returned +1437% versus RDNT's +947. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — RDNT or SMID?
By beta (market sensitivity over 5 years), RadNet, Inc.
(RDNT) is the lower-risk stock at 1. 43β versus Smith-Midland Corporation's 1. 58β — meaning SMID is approximately 11% more volatile than RDNT relative to the S&P 500. On balance sheet safety, Smith-Midland Corporation (SMID) carries a lower debt/equity ratio of 12% versus 137% for RadNet, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — RDNT or SMID?
By revenue growth (latest reported year), Smith-Midland Corporation (SMID) is pulling ahead at 31.
8% versus 11. 5% for RadNet, Inc. (RDNT). On earnings-per-share growth, the picture is similar: Smith-Midland Corporation grew EPS 866. 7% year-over-year, compared to -768. 4% for RadNet, Inc.. Over a 3-year CAGR, SMID leads at 15. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — RDNT or SMID?
Smith-Midland Corporation (SMID) is the more profitable company, earning 9.
8% net margin versus 2. 3% for RadNet, Inc. — meaning it keeps 9. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SMID leads at 12. 6% versus 3. 0% for RDNT. At the gross margin level — before operating expenses — SMID leads at 25. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — RDNT or SMID?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is RDNT or SMID better for a retirement portfolio?
For long-horizon retirement investors, Smith-Midland Corporation (SMID) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+1437% 10Y return).
Both have compounded well over 10 years (SMID: +1437%, RDNT: +947. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between RDNT and SMID?
These companies operate in different sectors (RDNT (Healthcare) and SMID (Basic Materials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: RDNT is a small-cap quality compounder stock; SMID is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.